GSI 705 (Truvada 167 mg / 250 mg)
Generic Name: emtricitabine/tenofovir
Pill with imprint GSI 705 is Blue, Capsule-shape and has been identified as Truvada 167 mg / 250 mg. It is supplied by Gilead Sciences, Inc.
Truvada is used in the treatment of pre-exposure prophylaxis; occupational exposure; hiv infection; nonoccupational exposure and belongs to the drug class antiviral combinations. There is no proven risk in humans during pregnancy. Truvada 167 mg / 250 mg is not a controlled substance under the Controlled Substances Act (CSA).
Images for GSI 705
Truvada
- Generic Name
- emtricitabine/tenofovir
- Imprint
- GSI 705
- Strength
- 167 mg / 250 mg
- Color
- Blue
- Size
- 18.00 mm
- Shape
- Capsule-shape
- Availability
- Prescription only
- Drug Class
- Antiviral combinations
- Pregnancy Category
- B - No proven risk in humans
- CSA Schedule
- Not a controlled drug
- Labeler / Supplier
- Gilead Sciences, Inc.
- National Drug Code (NDC)
- 61958-0705
- Inactive Ingredients
-
croscarmellose sodium,
lactose monohydrate,
magnesium stearate,
microcrystalline cellulose,
corn starch,
water,
FD&C Blue No. 2,
aluminum oxide,
titanium dioxide,
triacetin
Note: Inactive ingredients may vary.
More about Truvada (emtricitabine / tenofovir)
- Side effects
- Drug interactions
- Dosage information
- During pregnancy
- Reviews (34)
- Drug images
- Compare alternatives
- Pricing & coupons
- Generic availability
- En español
- Drug class: antiviral combinations
- FDA approval history
Patient resources
- Other brands
- AccessPak for HIV PEP Basic
Professional resources
Related treatment guides
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.